IDEAYA Biosciences, Inc. IDYA Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s other commercial liabilities?
- IDEAYA Biosciences, Inc. (IDYA) reported other commercial liabilities of $43.75M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s other commercial liabilities changed year-over-year?
- IDEAYA Biosciences, Inc.'s other commercial liabilities increased by 32.9% year-over-year, from $32.91M to $43.75M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s other commercial liabilities has grown at a 36.9% compound annual growth rate (CAGR), from $8.52M to $40.89M.